Koichi Takaguchi

Kagawa Prefectural Central Hospital

H指数:43

被引数:6,825

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ablation-Based Salvage Strategy at Disease Progression After Initial Disease Control With Atezolizumab/Bevacizumab in Hepatocellular Carcinoma

在初始使用阿替利珠单抗/贝伐珠单抗控制疾病后，疾病进展时基于消融的挽救策略在肝细胞癌中的应用

Hepatology Research

IF3.4

2026-05-110

PRE

Superior Efficacy of Tenofovir Alafenamide Compared With Entecavir in Reducing Hepatitis B Surface Antigen: A Multicentre Propensity Score-Matched Study Using Linear Mixed-Effects Models

与恩替卡韦相比，替诺福韦艾拉酚胺在降低乙型肝炎表面抗原方面的卓越疗效：一项使用线性混合效应模型的多中心倾向性评分匹配研究

ALIMENTARY PHARMACOLOGY & THERAPEUTICS

IF6.7

2026-05-040

PRE

Clinical Characteristics, Predictive Factors, and the Impact of Antithrombotic Therapy on Bleeding Events in Unresectable Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab

不可切除性肝细胞癌接受阿替利珠单抗联合贝伐珠单抗治疗后出血事件的临床特征、预测因素及抗血栓治疗的影响

Hepatology Research

IF3.4

2026-04-210

PRE

Fujimasa Tada; Atsushi Hiraoka; Hideko Ohama; Toshifumi Tada; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Shinya Fukunishi; Kunihiko Tsuji; Toru Ishikawa; Kazuto Tajiri; Hironori Tanaka; Hidenori Toyoda; Chikara Ogawa; Takashi Nishimura; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Atsushi Naganuma; Hisashi Kosaka; Tomomitsu Matono; Yoshihide Ueda; Hidekatsu Kuroda; Yutaka Yata; Hiroki Nishikawa; Michitaka Imai; Tomoko Aoki; Hironori Ochi; Jumpei Okamura; Hideyuki Tamai; Shinichiro Nakamura; Yoshiko Nakamura; Osamu Yoshida; Kazuhiro Nouso; Asahiro Morishita; Norio Itokawa; Tomomi Okubo; Taeang Arai; Akemi Tsutsui; Takuya Nagano; Kazunari Tanaka; Yuichi Koshiyama; Yuki Kanayama; Hidenao Noritake; Shohei Komatsu; Takumi Fukumoto; Takanori Matsuura; Soo Ki Kim; Hirayuki Enomoto; Kosuke Matsui; Masaki Kaibori; Yoichi Hiasa; Masatoshi Kudo; Takashi Kumada; the Real-life Practice Experts for HCC (RELPEC) Study Group and hepatocellular carcinoma experts from 48 clinics in Japan (HCC 48) Group

Lymphocyte–Monocyte Ratio Predicts the Survival in Patients With HCC Treated With Durvalumab Plus Tremelimumab

淋巴细胞-单核细胞比值预测接受度鲁单单抗联合曲美单抗治疗的HCC患者的生存情况

Liver International

IF5.2

2026-02-260

PRE

Tomomitsu Matono; Toshifumi Tada; Atsushi Hiraoka; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Takashi Nishimura; Kunihiko Tsuji; Toru Ishikawa; Kazuto Tajiri; Hironori Tanaka; Hidenori Toyoda; Chikara Ogawa; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Atsushi Naganuma; Hisashi Kosaka; Hidekatsu Kuroda; Yutaka Yata; Hiroki Nishikawa; Michitaka Imai; Tomoko Aoki; Hironori Ochi; Hideyuki Tamai; Shohei Komatsu; Takanori Matsuura; Yoshihide Ueda; Soo Ki Kim; Hideko Ohama; Fujimasa Tada; Shinichiro Nakamura; Yoshiko Nakamura; Osamu Yoshida; Kazuhiro Nouso; Asahiro Morishita; Norio Itokawa; Tomomi Okubo; Taeang Arai; Akemi Tsutsui; Takuya Nagano; Shinya Fukunishi; Kazunari Tanaka; Yuichi Koshiyama; Yuki Kanayama; Hidenao Noritake; Hirayuki Enomoto; Kosuke Matsui; Masaki Kaibori; Jumpei Okamura; Takumi Fukumoto; Yoichi Hiasa; Masatoshi Kudo; Takashi Kumada; the RELPEC Group and HCC 48 Group

Evolution of Hepatocellular Carcinoma Treatment Outcomes Over Two Decades in Japan: Improvements in Early-Stage Viral Disease

日本过去二十年间肝细胞癌治疗结果的演变：早期病毒性疾病的改善

HEPATOLOGY RESEARCH

IF3.4

2025-11-010

Identification of high-risk group for diabetes-associated hepatocellular carcinoma using noninvasive test for liver fibrosis

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

IF1.8

2025-11-010

PRE

Impact of Concurrent Steatotic Liver Disease and Chronic Hepatitis B on Treatment Response to Nucleos(t)ide Analogs

合并脂肪性肝病和慢性乙型肝炎对核苷（酸）类似物治疗反应的影响

JOURNAL OF VIRAL HEPATITIS

IF2.3

2025-10-010

PRE

Chau, Angela; Li, Jie; Jun, Dae Won; Hsu, Yao-Chun; Toyoda, Hidenori; Yeh, Ming-Lun; Watanabe, Tsunamasa; Honda, Takashi; Trinh, Huy; Nozaki, Akito; Uojima, Haruki; Ishikawa, Toru; Huang, Daniel Q.; Vutien, Philip; Marciano, Sebastian; Abe, Hiroshi; Atsukawa, Masanori; Enomoto, Masaru; Takahashi, Hirokazu; Tsuji, Kunihiko; Takaguchi, Koichi; Itobayashi, Ei; Huang, Rui; Tsai, Pei-Chien; Dai, Chia-Yen; Huang, Jee-Fu; Huang, Chung-Feng; Yoon, Eileen; Kim, Sung Eun; Ahn, Sang Bong; Kim, Gi-Ae; Jung, Jang Han; Jeong, Soung Won; Oh, Hyunwoo; Hsiao, Tiffany; Maeda, Mayumi; Tseng, Cheng-Hao; Yasuda, Satoshi; Ishigami, Masatoshi; Chuma, Makoto; Ito, Takanori; Kawashima, Keigo; Liu, Joanne Kimiko; Itokawa, Norio; Kozuka, Ritsuzo; Inoue, Kaori; Senoh, Tomonori; Chuang, Wan-Long; Gadano, Adrian; Tanaka, Yasuhito; Lim, Seng Gee; Wu, Chao; Cheung, Ramsey; Yu, Ming-Lung; Nguyen, Mindie H.

Clinical Utility of a Prognostic Scoring System Based on LDH and CRP in HCC Patients Receiving Atezolizumab Plus Bevacizumab

基于LDH和CRP的预后评分系统在应用阿替利珠单抗联合贝伐珠单抗治疗的HCC患者中的临床应用价值

LIVER INTERNATIONAL

IF5.2

2025-09-190

PRE

Tanaka, Kazunari; Tsuji, Kunihiko; Hiraoka, Atsushi; Tada, Toshifumi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Ishikawa, Toru; Tajiri, Kazuto; Ohama, Hideko; Toyoda, Hidenori; Ogawa, Chikara; Nishimura, Takashi; Hatanaka, Takeshi; Kakizaki, Satoru; Kawata, Kazuhito; Naganuma, Atsushi; Kosaka, Hisashi; Matono, Tomomitsu; Kuroda, Hidekatsu; Yata, Yutaka; Nishikawa, Hiroki; Imai, Michitaka; Aoki, Tomoko; Ochi, Hironori; Kanayama, Yuki; Tada, Fujimasa; Nakamura, Shinichiro; Nouso, Kazuhiro; Morishita, Asahiro; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Tsutsui, Akemi; Tanaka, Hironori; Noritake, Hidenao; Kaibori, Masaki; Hiasa, Yoichi; Kudo, Masatoshi; Kumada, Takashi

Efficacy and Safety of Durvalumab Plus Tremelimumab in Hepatocellular Carcinoma Patients With Portal Vein Thrombosis and High Tumor Burden: A Multicenter Retrospective Analysis

度鲁特玛联合特瑞普利单抗在合并门静脉血栓和高肿瘤负荷的肝细胞癌患者中的有效性与安全性：一项多中心回顾性分析

Hepatology Research

IF3.4

2025-09-060

PRE

Hatanaka, Takeshi; Yata, Yutaka; Hiraoka, Atsushi; Tada, Toshifumi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Kakizaki, Satoru; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Toyoda, Hidenori; Koshiyama, Yuichi; Ogawa, Chikara; Nishikawa, Hiroki; Nishimura, Takashi; Kawata, Kazuhito; Kosaka, Hisashi; Matsui, Kosuke; Naganuma, Atsushi; Tanaka, Hironori; Ohama, Hideko; Kuroda, Hidekatsu; Matono, Tomomitsu; Aoki, Tomoko; Ochi, Hironori; Imai, Michitaka; Nakamura, Shinichiro; Komatsu, Shohei; Tamai, Hideyuki; Okamura, Jumpei; Kanayama, Yuki; Tanaka, Kazunari; Tada, Fujimasa; Yoshida, Osamu; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Matsuura, Takanori; Noritake, Hidenao; Enomoto, Hirayuki; Kaibori, Masaki; Fukumoto, Takumi; Hiasa, Yoichi; Kudo, Masatoshi; Kumada, Takashi

Potential role of Geriatric Nutritional Risk Index as a risk factor for immune-mediated adverse events during durvalumab plus tremelimumab therapy in unresectable hepatocellular carcinoma

格瑞特营养风险指数作为不可切除肝癌患者接受度伐利尤单抗联合特瑞普利单抗治疗期间免疫介导不良反应的风险因素的潜在作用

Journal of Gastroenterology

IF5.5

2025-08-200

PRE

Hideko Ohama; Atsushi Hiraoka; Toshifumi Tada; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Shinya Fukunishi; Kunihiko Tsuji; Toru Ishikawa; Kazuto Tajiri; Hironori Tanaka; Hidenori Toyoda; Chikara Ogawa; Takashi Nishimura; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Atsushi Naganuma; Hisashi Kosaka; Tomomitsu Matono; Hidekatsu Kuroda; Yutaka Yata; Hiroki Nishikawa; Michitaka Imai; Tomoko Aoki; Hironori Ochi; Hideyuki Tamai; Shohei Komatsu; Fujimasa Tada; Shinichiro Nakamura; Yoshiko Nakamura; Teruki Miyake; Osamu Yoshida; Kazuhiro Nouso; Asahiro Morishita; Norio Itokawa; Tomomi Okubo; Taeang Arai; Akemi Tsutsui; Takuya Nagano; Kazunari Tanaka; Takanori Matsuura; Yuichi Koshiyama; Yuki Kanayama; Hidenao Noritake; Hirayuki Enomoto; Kosuke Matsui; Masaki Kaibori; Takumi Fukumoto; Yoichi Hiasa; Masatoshi Kudo; Takashi Kumada

Impact of metabolic dysfunction on treatment responses to nucleos(t)ide analogues in chronic hepatitis B: a retrospective multi-center REAL-B cohort study

代谢功能障碍对核苷(酸)类似物治疗慢性乙型肝炎反应的影响：一项回顾性多中心REAL-B队列研究

eClinicalMedicine

IF10

2025-08-110

PREAI

Rui Huang; Dae Won Jun; Hidenori Toyoda; Yao-Chun Hsu; Huy Trinh; Akito Nozaki; Toru Ishikawa; Tsunamasa Watanabe; Haruki Uojima; Daniel Q. Huang; Takashi Honda; Yasuhito Tanaka; Philip Vutien; Sebastián Marciano; Hiroshi Abe; Masaru Enomoto; Masanori Atsukawa; Hirokazu Takahashi; Kunihiko Tsuji; Ei Itobayashi; Koichi Takaguchi; Pei-Chien Tsai; Chia-Yen Dai; Jee-Fu Huang; Chung-Feng Huang; Ming-Lun Yeh; Eileen Yoon; Sung Eun Kim; Sang Bong Ahn; Gi-Ae Kim; Jang Han Jung; Soung Won Jeong; Hyunwoo Oh; Cheng-Hao Tseng; Masatoshi Ishigami; Angela Chau; Tiffany Hsiao; Mayumi Maeda; Satoshi Yasuda; Makoto Chuma; Takanori Ito; Keigo Kawashima; Joanne Kimiko Liu; Adrian Gadano; Ritsuzo Kozuka; Norio Itokawa; Kaori Inoue; Tomonori Senoh; Jie Li; Wan-Long Chuang; Ramsey Cheung; Chao Wu; Ming-Lung Yu; Mindie H. Nguyen

Safety and Efficacy of Durvalumab Plus Tremelimumab in Older Individuals With Unresectable Hepatocellular Carcinoma: A Multicenter Analysis

达鲁瓦鲁单抗联合特雷美鲁单抗在不可切除肝细胞癌老年患者中的安全性与有效性：一项多中心分析

Hepatology Research

IF3.4

2025-08-060

PRE

Tomomitsu Matono; Toshifumi Tada; Takashi Kumada; Atsushi Hiraoka; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Shinya Fukunishi; Hiroki Nishikawa; Kazunari Tanaka; Kunihiko Tsuji; Toru Ishikawa; Kazuto Tajiri; Yuichi Koshiyama; Hidenori Toyoda; Chikara Ogawa; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Hidenao Noritake; Hideko Ohama; Fujimasa Tada; Kazuhiro Nouso; Asahiro Morishita; Akemi Tsutsui; Takuya Nagano; Norio Itokawa; Tomomi Okubo; Taeang Arai; Takashi Nishimura; Michitaka Imai; Hisashi Kosaka; Atsushi Naganuma; Tomoko Aoki; Hidekatsu Kuroda; Yutaka Yata; Hideyuki Tamai; Takanori Matsuura; Shohei Komatsu; Yoshihide Ueda; Yoshiko Nakamura; Osamu Yoshida; Kosuke Matsui; Shinichiro Nakamura; Hirayuki Enomoto; Masaki Kaibori; Takumi Fukumoto; Yoichi Hiasa; Masatoshi Kudo; the Real-life Practice Experts for HCC (RELPEC) Study Group and the Hepatocellular Carcinoma Experts From 48 Clinics in Japan (HCC 48) Group

Vascular Invasion Within the Resectability Criteria Is a Prognostic Factor in Patients Treated With Atezolizumab and Bevacizumab

在可切除性标准范围内的血管浸润是接受阿替利珠单抗和贝伐珠单抗治疗患者的预后因素

Liver International

IF5.2

2025-07-070

PRE

Neutrophil–Lymphocyte Ratio Predicts Overall Survival in Patients With HCC Treated With Durvalumab Plus Tremelimumab

中性粒细胞–淋巴细胞比值预测接受度鲁单抗联合特瑞普利单抗治疗患者的总体生存期

Hepatology Research

IF3.4

2025-06-140

PRE

Impact of time-of-day atezolizumab plus bevacizumab combination therapy infusion for unresectable hepatocellular carcinoma: A retrospective multicenter study

HEPATOLOGY RESEARCH

IF3.4

2025-02-090

PRE

Naganuma, Atsushi; Kakizaki, Satoru; Hatanaka, Takeshi; Hiraoka, Atsushi; Tada, Toshifumi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Toyoda, Hidenori; Koshiyama, Yuichi; Ogawa, Chikara; Nishikawa, Hiroki; Nishimura, Takashi; Kawata, Kazuhito; Kosaka, Hisashi; Matsui, Kosuke; Yata, Yutaka; Tanaka, Hironori; Ohama, Hideko; Kuroda, Hidekatsu; Matono, Tomomitsu; Aoki, Tomoko; Ochi, Hironori; Imai, Michitaka; Nakamura, Shinichiro; Kanayama, Yuki; Tanaka, Kazunari; Tada, Fujimasa; Yoshida, Osamu; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Enomoto, Hirayuki; Kaibori, Masaki; Hiasa, Yoichi; Kudo, Masatoshi; Kumada, Takashi

Survival Outcomes Associated With Radiological Progressive Disease Subtypes in Patients With Atezolizumab and Bevacizumab-Treated HCC

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

IF3.4

2025-01-220

PRE

Matono, Tomomitsu; Tada, Toshifumi; Kumada, Takashi; Hiraoka, Atsushi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Nishikawa, Hiroki; Tanaka, Kazunari; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Koshiyama, Yuichi; Toyoda, Hidenori; Ogawa, Chikara; Hatanaka, Takeshi; Kakizaki, Satoru; Kawata, Kazuhito; Ohama, Hideko; Tada, Fujimasa; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Nishimura, Takashi; Imai, Michitaka; Kosaka, Hisashi; Naganuma, Atsushi; Aoki, Tomoko; Kuroda, Hidekatsu; Yata, Yutaka; Nakamura, Yoshiko; Yoshida, Osamu; Nakamura, Shinichiro; Enomoto, Hirayuki; Kaibori, Masaki; Hiasa, Yoichi; Kudo, Masatoshi

Reliable Performance of mALBI Grade-Based Risk Models for Predicting the Prognosis of Patients With Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab as First-Line Treatment: Comparative Analysis of 13 Risk Models

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

IF3.4

2025-01-060

PRE

Hatanaka, Takeshi; Kakizaki, Satoru; Hiraoka, Atsushi; Tada, Toshifumi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Toyoda, Hidenori; Ogawa, Chikara; Nishikawa, Hiroki; Nishimura, Takashi; Kawata, Kazuhito; Kosaka, Hisashi; Naganuma, Atsushi; Yata, Yutaka; Ohama, Hideko; Kuroda, Hidekatsu; Matono, Tomomitsu; Tanaka, Kazunari; Tada, Fujimasa; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Imai, Michitaka; Koizumi, Yohei; Nakamura, Shinichiro; Kaibori, Masaki; Iijima, Hiroko; Hiasa, Yoichi; Kumada, Takashi

Geriatric nutritional risk index and newly developed scoring system as prognosis prediction for unresectable hepatocellular carcinoma patients treated with lenvatinib

老年营养风险指数和新开发的评分系统可作为lenvatinib治疗不可切除的肝细胞癌患者的预后预测

SCIENTIFIC REPORTS

IF3.9

2025-01-021

OAAI

Ohama, Hideko; Hiraoka, Atsushi; Tada, Toshifumi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Ochi, Hironori; Yasuda, Satoshi; Toyoda, Hidenori; Ogawa, Chikara; Nishimura, Takashi; Hatanaka, Takeshi; Kakizaki, Satoru; Shimada, Noritomo; Kawata, Kazuhito; Naganuma, Atsushi; Kosaka, Hisashi; Matono, Tomomitsu; Kuroda, Hidekatsu; Yata, Yutaka; Tanaka, Hironori; Nishikawa, Hiroki; Shibata, Hiroshi; Tada, Fujimasa; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Imai, Michitaka; Koizumi, Yohei; Nakamura, Shinichiro; Iijima, Hiroko; Kaibori, Masaki; Hiasa, Yoichi; Kumada, Takashi

Efficacy of durvalumab plus tremelimumab treatment for unresectable hepatocellular carcinoma in immunotherapy era clinical practice

免疫治疗时代临床实践中durvalumab联合tremelimumab治疗不可切除肝细胞癌的疗效

HEPATOLOGY RESEARCH

IF3.4

2024-11-112

Hiraoka, Atsushi; Tada, Toshifumi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Ohama, Hideko; Toyoda, Hidenori; Ogawa, Chikara; Nishimura, Takashi; Hatanaka, Takeshi; Kakizaki, Satoru; Kawata, Kazuhito; Naganuma, Atsushi; Kosaka, Hisashi; Matono, Tomomitsu; Kuroda, Hidekatsu; Yata, Yutaka; Nishikawa, Hiroki; Imai, Michitaka; Aoki, Tomoko; Ochi, Hironori; Tada, Fujimasa; Nakamura, Shinichiro; Nakamura, Yoshiko; Nouso, Kazuhiro; Morishita, Asahiro; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Tsutsui, Akemi; Nagano, Takuya; Tanaka, Kazunari; Tanaka, Hironori; Koshiyama, Yuichi; Kanayama, Yuki; Noritake, Hidenao; Enomoto, Hirayuki; Kaibori, Masaki; Hiasa, Yoichi; Kudo, Masatoshi; Kumada, Takashi

Predictive factors and survival outcome of conversion therapy for unresectable hepatocellular carcinoma patients receiving atezolizumab and bevacizumab: Comparative analysis of conversion, partial response and complete response patients

ALIMENTARY PHARMACOLOGY & THERAPEUTICS

IF6.7

2024-09-043

PRE

Hatanaka, Takeshi; Kakizaki, Satoru; Hiraoka, Atsushi; Tada, Toshifumi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Toyoda, Hidenori; Ogawa, Chikara; Nishikawa, Hiroki; Nishimura, Takashi; Kawata, Kazuhito; Kosaka, Hisashi; Naganuma, Atsushi; Yata, Yutaka; Ohama, Hideko; Kuroda, Hidekatsu; Matono, Tomomitsu; Aoki, Tomoko; Kanayama, Yuki; Tanaka, Kazunari; Tada, Fujimasa; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Imai, Michitaka; Nakamura, Shinichiro; Enomoto, Hirayuki; Kaibori, Masaki; Hiasa, Yoichi; Kudo, Masatoshi; Kumada, Takashi

Koichi Takaguchi

个人简介

教育背景

工作经历

荣誉奖项

研究方向